Genentech, Inc. recalls
Every recall we track for Genentech, Inc. — 11 in all, from 2012–2024 — plus the complaints and injury reports the public filed about them. 2 are rated “stop using now”.
Recalls per year, by danger level
7 recalls since 2017. 14% rated “stop using now”.
All FDA recall records for Genentech, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 1 | 1 | 2 |
| 2018 | 0 | 0 | 1 | 0 | 1 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 1 | 1 | 2 |
| 2022 | 0 | 0 | 1 | 0 | 1 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Genentech, Inc. recalls before 2017
Recalls on record by year.
What to do if you have a recalled Genentech, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Genentech, Inc. recalls
10 shown- Stop using nowDrug
Genentech, Inc. recalls Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64
Genentech recalls 2mg Cathflo Activase vials with deformed stoppers that may cause contamination. Affected lots expire 01/31/2026. Stop using immediately to avoid infection risks.
GenentechMay 20, 2024 - Lower riskDrug
Genentech Inc recalls Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One
Genentech recalls Susvimo (ranibizumab injection) due to defective delivery system causing implants to become non-functional. Affected lots expire by 2027.
GenentechOct 18, 2022 - UnratedDrug
Genentech Inc recalls Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Subcutaneous Use. Single-Dose Prefilled
Genentech recalls Xolair 150mg prefilled syringes due to stability problems detected at 12 months. Affected lots expired August 2021. No remedy specified in official notice.
GenentechJun 9, 2021 - Lower riskDrug
Genentech Inc recalls Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only,
Genentech recalls Evrysdi oral solution due to incorrect bottle adapters that may not fit with syringes, risking improper medication delivery.
GenentechApr 20, 2021 - Lower riskDrug
Genentech, Inc. recalls Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A
Genentech recalls 0.5mg Klonopin tablets due to missing Schedule IV controlled substance label on packaging. This could lead to improper use or diversion. Check your product details and contact Genentech for instructions.
GenentechFeb 5, 2018 - UnratedDrug
Genentech, Inc. recalls Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water
Genentech recalls 58 million IU Activase vials due to cracked glass in sterile water vials, posing contamination risks. Consumers should check for cracks and contact Genentech for details.
GenentechSep 5, 2017 - Lower riskDrug
Genentech Inc. recalls Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA,
Genentech recalls 20mg cobimetinib tablets with an oversized tablet found in the bottle. This could cause incorrect dosing if taken. Contact Genentech for details.
GenentechMar 13, 2017 - Use cautionDrug
Genentech, Inc. recalls CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05;
Genentech recalls specific lots of CellCept (mycophenolate mofetil) capsules because some bottles contain fewer than the labeled 120-count.
GenentechSep 27, 2012 - Use cautionDrug
Genentech Inc recalls Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080,
Genentech recalls specific lots of Nutropin AQ NuSpin 20 injections due to miscalibrated delivery systems causing slow dose delivery.
GenentechSep 20, 2012 - Stop using nowDrug
Genentech Inc recalls Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic
Genentech recalls 2,140 Trastuzumab Kits due to potential glass particulates in the Bacteriostatic Water diluent vial. Check lot numbers if you have this investigational drug.
GenentechJul 30, 2012
Genentech, Inc. recall questions
How many recalls has Genentech, Inc. had?
11 recalls from Genentech, Inc. are on record with U.S. safety agencies, from 2012–2024.
What is the most recent Genentech, Inc. recall?
Genentech, Inc. recalls Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64, dated May 20, 2024. Every Genentech, Inc. recall is listed on this page, newest first.
What should I do if I have a recalled Genentech, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Genentech, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.